Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical Analysis of Driver Mutations in Patients with Ph Negative Myeloproliferative Neoplasms].

Zhongguo shi yan xue ye xue za zhi - 1 Jun 2018

He Zhi-Peng, Tian Hui-Yun, Tan Ming, Wu Yong

Abstract excerpt

OBJECTIVE: To explore the relationship between driver mutations and clinical characteristics in patients with Philadelphia chromosome (Ph) negative myeloproliferative neoplasms (MPN), so as to provide evidence for diagno-sis and treatment of the disease. METHODS: The clinical data of 410 patients with classic Ph negative MPN including 150 cases of polycythemia vera (PV), 188 cases of essential thrombocythemia...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calreticulin
Share to CALR gene
Share to JAK2 gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to MPL gene

Share to Janus Kinase 2

Share to Mutation

Share to Primary Myelofibrosis

Share to Thrombocythemia, Essential

Source

Identifiers

PMID: 29950230
DOI: 10.7534/j.issn.1009-2137.2018.03.035

Genes

JAK2
CALR
MPL

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical Analysis of Driver Mutations in Patients with Ph Negative Myeloproliferative Neoplasms].PMID 29950230Read ↗

Analysis of Common Driver Mutations in Philadelphia-Negative Myeloproliferative Neoplasms.Semantic proximity Read ↗

[The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms].Semantic proximity Read ↗

A Rare Case of Essential Thrombocythemia with Coexisting JAK2 and MPL Driver Mutations.Semantic proximity Read ↗

[Clinical significance of JAK2、CALR and MPL gene mutations in 1 648 Philadelphia chromosome negative myeloproliferative neoplasms patients from a single center].Semantic proximity Read ↗

[Analysis of gene mutations and clinic features in 108 patients with myeloproliferative neoplasm].Semantic proximity Read ↗

Clonal Hematopoiesis and Mutations of Myeloproliferative NeoplasmsSemantic proximity Read ↗

Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.Semantic proximity Read ↗

[Search for mutations in patients with Philadelphia negative myeloproliferative neoplasms in a public hospital in Chile].Semantic proximity Read ↗

[Clinical and epidemiological characteristics of the Philadelphia negative myeloproliferative neoplasms in Chile].Semantic proximity Read ↗

[Clinical and epidemiological characteristics of the Philadelphia negative myeloproliferative neoplasms in Chile].Semantic proximity Read ↗

Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.